Resalis Therapeutics
- Biotech or pharma, therapeutic R&D
Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity.
Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity.